Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Plus Grants Program

McMaster University

$12,500.00

Aptamers for omega-3 fatty acids

FY 2014-15

Summary
Omega-3 fatty acids (Omega-3) are very important to human health, but more than 70% of Canadians are Omega-3 deficient. Currently, Omega-3 status of individuals is determined via blood test in private laboratories using a method that is old, tedious, and time consuming. Pivotal Therapeutics Inc has been interested in developing a rapid test that can be performed at the point of care (POC) or by individuals themselves to monitor their Omega-3 status. However, the major hindrance for developing such a test is lack of availability of any recognition probes that are specific for Omega-3. Through an awarded Engage grant, Pivotal has been collaborating with Dr. Yingfu Li at McMaster University to develop DNA aptamer based molecular probes for Omega-3, and together the team has made significant progress, and have isolated several aptamers that can differentially recognize various Omega fatty acids. Through this Engage Plus grant Pivotal and Dr. Li will keepthe research momentum going when the team is working on securing a longer term research grant to fully develop these novel aptamer reagents towards the creation of a user-friendly Omega-3 diagnostic test. The progress that has been made via the awarded Engage grant and the work to be pursued in this proposed Engage Plus grant represent important steps towards development of a novel POC device that will determine the Omega-3 status of individuals quickly and conveniently allowing the Canadian population in general to self-monitor and correct a nutritional deficiency of Omega-3.
Program
Engage Plus Grants Program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
470444-2014
Name nom
Li, Yingfu
Department département
Biochemistry and Biomedical Sciences
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2014
Award amount
12500
Program id
EGP2
Program name en
Engage Plus Grants Program
Program name fr
Programme de subvention d'engagement partenarial Plus
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5402
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Nucleic acids
Research subject fr
Acides nucléiques
Partie
1
Nb partie
1
Application title
Aptamers for omega-3 fatty acids
Keyword
NSERC
Application summary
Omega-3 fatty acids (Omega-3) are very important to human health, but more than 70% of Canadians are Omega-3 deficient. Currently, Omega-3 status of individuals is determined via blood test in private laboratories using a method that is old, tedious, and time consuming. Pivotal Therapeutics Inc has been interested in developing a rapid test that can be performed at the point of care (POC) or by individuals themselves to monitor their Omega-3 status. However, the major hindrance for developing such a test is lack of availability of any recognition probes that are specific for Omega-3. Through an awarded Engage grant, Pivotal has been collaborating with Dr. Yingfu Li at McMaster University to develop DNA aptamer based molecular probes for Omega-3, and together the team has made significant progress, and have isolated several aptamers that can differentially recognize various Omega fatty acids. Through this Engage Plus grant Pivotal and Dr. Li will keepthe research momentum going when the team is working on securing a longer term research grant to fully develop these novel aptamer reagents towards the creation of a user-friendly Omega-3 diagnostic test. The progress that has been made via the awarded Engage grant and the work to be pursued in this proposed Engage Plus grant represent important steps towards development of a novel POC device that will determine the Omega-3 status of individuals quickly and conveniently allowing the Canadian population in general to self-monitor and correct a nutritional deficiency of Omega-3.